187 related articles for article (PubMed ID: 17470431)
21. Antibody-based exosite inhibitors of ADAMTS-5 (aggrecanase-2).
Santamaria S; Yamamoto K; Botkjaer K; Tape C; Dyson MR; McCafferty J; Murphy G; Nagase H
Biochem J; 2015 Nov; 471(3):391-401. PubMed ID: 26303525
[TBL] [Abstract][Full Text] [Related]
22. Sites of aggrecan cleavage by recombinant human aggrecanase-1 (ADAMTS-4).
Tortorella MD; Pratta M; Liu RQ; Austin J; Ross OH; Abbaszade I; Burn T; Arner E
J Biol Chem; 2000 Jun; 275(24):18566-73. PubMed ID: 10751421
[TBL] [Abstract][Full Text] [Related]
23. Functional differences of the catalytic and non-catalytic domains in human ADAMTS-4 and ADAMTS-5 in aggrecanolytic activity.
Fushimi K; Troeberg L; Nakamura H; Lim NH; Nagase H
J Biol Chem; 2008 Mar; 283(11):6706-16. PubMed ID: 18156631
[TBL] [Abstract][Full Text] [Related]
24. Analysis of aggrecan in human knee cartilage and synovial fluid indicates that aggrecanase (ADAMTS) activity is responsible for the catabolic turnover and loss of whole aggrecan whereas other protease activity is required for C-terminal processing in vivo.
Sandy JD; Verscharen C
Biochem J; 2001 Sep; 358(Pt 3):615-26. PubMed ID: 11535123
[TBL] [Abstract][Full Text] [Related]
25. Development and characterization of a highly specific and sensitive sandwich ELISA for detection of aggrecanase-generated aggrecan fragments.
Pratta MA; Su JL; Leesnitzer MA; Struglics A; Larsson S; Lohmander LS; Kumar S
Osteoarthritis Cartilage; 2006 Jul; 14(7):702-13. PubMed ID: 16549371
[TBL] [Abstract][Full Text] [Related]
26. The development and characterization of a competitive ELISA for measuring active ADAMTS-4 in a bovine cartilage ex vivo model.
He Y; Zheng Q; Simonsen O; Petersen KK; Christiansen TG; Karsdal MA; Bay-Jensen AC
Matrix Biol; 2013 Apr; 32(3-4):143-51. PubMed ID: 23295731
[TBL] [Abstract][Full Text] [Related]
27. Regulation of aggrecanases from the ADAMTS family and aggrecan neoepitope formation during in vitro chondrogenesis of human mesenchymal stem cells.
Boeuf S; Graf F; Fischer J; Moradi B; Little CB; Richter W
Eur Cell Mater; 2012 May; 23():320-32. PubMed ID: 22562232
[TBL] [Abstract][Full Text] [Related]
28. Distinguishing aggrecan loss from aggrecan proteolysis in ADAMTS-4 and ADAMTS-5 single and double deficient mice.
Ilic MZ; East CJ; Rogerson FM; Fosang AJ; Handley CJ
J Biol Chem; 2007 Dec; 282(52):37420-8. PubMed ID: 17938173
[TBL] [Abstract][Full Text] [Related]
29. Evidence of a novel aggrecan-degrading activity in cartilage: Studies of mice deficient in both ADAMTS-4 and ADAMTS-5.
Rogerson FM; Stanton H; East CJ; Golub SB; Tutolo L; Farmer PJ; Fosang AJ
Arthritis Rheum; 2008 Jun; 58(6):1664-73. PubMed ID: 18512787
[TBL] [Abstract][Full Text] [Related]
30. Proteolytic activities of human ADAMTS-5: comparative studies with ADAMTS-4.
Gendron C; Kashiwagi M; Lim NH; Enghild JJ; Thøgersen IB; Hughes C; Caterson B; Nagase H
J Biol Chem; 2007 Jun; 282(25):18294-18306. PubMed ID: 17430884
[TBL] [Abstract][Full Text] [Related]
31. MMP proteolysis of the human extracellular matrix protein aggrecan is mainly a process of normal turnover.
Struglics A; Hansson M
Biochem J; 2012 Sep; 446(2):213-23. PubMed ID: 22670872
[TBL] [Abstract][Full Text] [Related]
32. ADAMTS-4 and ADAMTS-5: key enzymes in osteoarthritis.
Verma P; Dalal K
J Cell Biochem; 2011 Dec; 112(12):3507-14. PubMed ID: 21815191
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of ADAMTS4 (aggrecanase-1) by tissue inhibitors of metalloproteinases (TIMP-1, 2, 3 and 4).
Hashimoto G; Aoki T; Nakamura H; Tanzawa K; Okada Y
FEBS Lett; 2001 Apr; 494(3):192-5. PubMed ID: 11311239
[TBL] [Abstract][Full Text] [Related]
34. Drug insight: aggrecanases as therapeutic targets for osteoarthritis.
Fosang AJ; Little CB
Nat Clin Pract Rheumatol; 2008 Aug; 4(8):420-7. PubMed ID: 18577998
[TBL] [Abstract][Full Text] [Related]
35. ADAMTS4 (aggrecanase-1) interaction with the C-terminal domain of fibronectin inhibits proteolysis of aggrecan.
Hashimoto G; Shimoda M; Okada Y
J Biol Chem; 2004 Jul; 279(31):32483-91. PubMed ID: 15161923
[TBL] [Abstract][Full Text] [Related]
36. Calcium pentosan polysulfate directly inhibits enzymatic activity of ADAMTS4 (aggrecanase-1) in osteoarthritic chondrocytes.
Takizawa M; Yatabe T; Okada A; Chijiiwa M; Mochizuki S; Ghosh P; Okada Y
FEBS Lett; 2008 Aug; 582(19):2945-9. PubMed ID: 18671975
[TBL] [Abstract][Full Text] [Related]
37. A microplate assay for the screening of ADAMTS-4 inhibitors.
Thomas M; Sabatini M; Bensaude F; Mignard B; Ortuno JC; Caron I; Boutin JA; Ferry G
Matrix Biol; 2006 May; 25(4):261-7. PubMed ID: 16442274
[TBL] [Abstract][Full Text] [Related]
38. ADAMTS4 (aggrecanase-1) activation on the cell surface involves C-terminal cleavage by glycosylphosphatidyl inositol-anchored membrane type 4-matrix metalloproteinase and binding of the activated proteinase to chondroitin sulfate and heparan sulfate on syndecan-1.
Gao G; Plaas A; Thompson VP; Jin S; Zuo F; Sandy JD
J Biol Chem; 2004 Mar; 279(11):10042-51. PubMed ID: 14701864
[TBL] [Abstract][Full Text] [Related]
39. Characterization of an ADAMTS-5-mediated cleavage site in aggrecan in OSM-stimulated bovine cartilage.
Durigova M; Soucy P; Fushimi K; Nagase H; Mort JS; Roughley PJ
Osteoarthritis Cartilage; 2008 Oct; 16(10):1245-52. PubMed ID: 18372197
[TBL] [Abstract][Full Text] [Related]
40. Aggrecanases and aggrecanase-generated fragments in the human intervertebral disc at early and advanced stages of disc degeneration.
Patel KP; Sandy JD; Akeda K; Miyamoto K; Chujo T; An HS; Masuda K
Spine (Phila Pa 1976); 2007 Nov; 32(23):2596-603. PubMed ID: 17978660
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
